The Obesity Puzzle in the Era of GLP-1s - European Medical Journal

This site is intended for healthcare professionals

The Obesity Puzzle in the Era of GLP-1s

EMJ Podcast | Quickfire & Deep Dive

In this series, host Saranya Ravindran speaks with Holly Wyatt about the evolving landscape of obesity treatment in the era of glucagon-like peptide-1 (GLP-1) medications. From the mindset behind sustained weight loss to lifestyle design and medication exit strategies, this series explores how psychology, habits, and medical innovation intersect to solve the obesity puzzle. 

Speaker Bio:

Holly Wyatt is a Professor in the Department of Nutrition Sciences at the University of Alabama at Birmingham, USA. A leader in obesity medicine, she co-founded the State of Slim programme and specialises in long-term weight management and behaviour change. 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.